United States · FDA National Drug Code directory
topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-141_48ba6ac8-7f36-4a5c-8055-295af6083862
- Product NDC
- 68382-141
- Form
- TABLET, FILM COATED
- Composition / generic term
- topiramate
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090327
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (68382-141-01) · 68382-141-01
- 500 TABLET, FILM COATED in 1 BOTTLE (68382-141-05) · 68382-141-05
- 60 TABLET, FILM COATED in 1 BOTTLE (68382-141-14) · 68382-141-14
- 90 TABLET, FILM COATED in 1 BOTTLE (68382-141-16) · 68382-141-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →